Selected research
Market Structure
Global Iopamidol Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Iopamidol Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Iopamidol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Iopamidol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Iopamidol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Iopamidol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Iopamidol Injection include Bracco Imaging, Sanochemia and BeiLu Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Iopamidol Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Iopamidol Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Iopamidol Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Iopamidol Injection market size, projected growth trends, production technologies, key applications, and end-use industries.
Iopamidol Injection Segment by Company
Bracco Imaging
Sanochemia
BeiLu Pharma
Iopamidol Injection Segment by Type
9 g I/ 30 mL
11.1 g I/ 30 mL
Others
Iopamidol Injection Segment by Application
Hospitals
Clinics
Iopamidol Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Iopamidol Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Iopamidol Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Iopamidol Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Iopamidol Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Iopamidol Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Iopamidol Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Iopamidol Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 9 g I/ 30 mL
- 11.1 g I/ 30 mL
- Others
Applications
- Hospitals
- Clinics
Companies covered
- Bracco Imaging
- Sanochemia
- BeiLu Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Iopamidol Injection Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Iopamidol Injection Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Iopamidol Injection Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Iopamidol Injection Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Iopamidol Injection Market Dynamics
- 2.1 Iopamidol Injection Industry Trends
- 2.2 Iopamidol Injection Industry Drivers
- 2.3 Iopamidol Injection Industry Opportunities and Challenges
- 2.4 Iopamidol Injection Industry Restraints
3 Iopamidol Injection Market by Manufacturers
- 3.1 Global Iopamidol Injection Revenue by Manufacturers (2021-2026)
- 3.2 Global Iopamidol Injection Sales by Manufacturers (2021-2026)
- 3.3 Global Iopamidol Injection Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Iopamidol Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Iopamidol Injection Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Iopamidol Injection Manufacturers, Product Type & Application
- 3.7 Global Iopamidol Injection Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Iopamidol Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Iopamidol Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Iopamidol Injection Tier 1, Tier 2, and Tier 3
4 Iopamidol Injection Market by Type
- 4.1 Iopamidol Injection Type Introduction
- 4.1.1 9 g I/ 30 mL
- 4.1.2 11.1 g I/ 30 mL
- 4.1.3 Others
- 4.2 Global Iopamidol Injection Sales by Type
- 4.2.1 Global Iopamidol Injection Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Iopamidol Injection Sales by Type (2021-2032)
- 4.2.3 Global Iopamidol Injection Sales Market Share by Type (2021-2032)
- 4.3 Global Iopamidol Injection Revenue by Type
- 4.3.1 Global Iopamidol Injection Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Iopamidol Injection Revenue by Type (2021-2032)
- 4.3.3 Global Iopamidol Injection Revenue Market Share by Type (2021-2032)
5 Iopamidol Injection Market by Application
- 5.1 Iopamidol Injection Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.2 Global Iopamidol Injection Sales by Application
- 5.2.1 Global Iopamidol Injection Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Iopamidol Injection Sales by Application (2021-2032)
- 5.2.3 Global Iopamidol Injection Sales Market Share by Application (2021-2032)
- 5.3 Global Iopamidol Injection Revenue by Application
- 5.3.1 Global Iopamidol Injection Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Iopamidol Injection Revenue by Application (2021-2032)
- 5.3.3 Global Iopamidol Injection Revenue Market Share by Application (2021-2032)
6 Global Iopamidol Injection Sales by Region
- 6.1 Global Iopamidol Injection Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Iopamidol Injection Sales by Region (2021-2032)
- 6.2.1 Global Iopamidol Injection Sales by Region (2021-2026)
- 6.2.2 Global Iopamidol Injection Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Iopamidol Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Iopamidol Injection Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Iopamidol Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Iopamidol Injection Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Iopamidol Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Iopamidol Injection Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Iopamidol Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Iopamidol Injection Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Iopamidol Injection Revenue by Region
- 7.1 Global Iopamidol Injection Revenue by Region
- 7.1.1 Global Iopamidol Injection Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Iopamidol Injection Revenue by Region (2021-2026)
- 7.1.3 Global Iopamidol Injection Revenue by Region (2027-2032)
- 7.1.4 Global Iopamidol Injection Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Iopamidol Injection Revenue (2021-2032)
- 7.2.2 North America Iopamidol Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Iopamidol Injection Revenue (2021-2032)
- 7.3.2 Europe Iopamidol Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Iopamidol Injection Revenue (2021-2032)
- 7.4.2 Asia-Pacific Iopamidol Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Iopamidol Injection Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Iopamidol Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Bracco Imaging
- 8.1.1 Bracco Imaging Company Information
- 8.1.2 Bracco Imaging Business Overview
- 8.1.3 Bracco Imaging Iopamidol Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Bracco Imaging Iopamidol Injection Product Portfolio
- 8.1.5 Bracco Imaging Recent Developments
- 8.2 Sanochemia
- 8.2.1 Sanochemia Company Information
- 8.2.2 Sanochemia Business Overview
- 8.2.3 Sanochemia Iopamidol Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sanochemia Iopamidol Injection Product Portfolio
- 8.2.5 Sanochemia Recent Developments
- 8.3 BeiLu Pharma
- 8.3.1 BeiLu Pharma Company Information
- 8.3.2 BeiLu Pharma Business Overview
- 8.3.3 BeiLu Pharma Iopamidol Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 BeiLu Pharma Iopamidol Injection Product Portfolio
- 8.3.5 BeiLu Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Iopamidol Injection Value Chain Analysis
- 9.1.1 Iopamidol Injection Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Iopamidol Injection Production Mode & Process
- 9.2 Iopamidol Injection Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Iopamidol Injection Distributors
- 9.2.3 Iopamidol Injection Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst